Medtronic’s OmniaSecure defibrillation lead earns expanded FDA indication

The OmniaSecure lead gained the first U.S. approval for placement in the heart’s left bundle branch area, to help activate ...
Medical Device Network on MSN

Medtronic’s OmniaSecure defib lead nets another FDA approval

OmniaSecure is now the first defibrillation lead approved for placement in the left bundle branch.
MassDevice

Medtronic wins expanded FDA approval for OmniaSecure for conduction pacing

Medtronic announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.

Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) ...
Medical Device and Diagnostic Industry (MD+DI)

Medtronic’s Tiny Defibrillation Lead Packs a Big Punch

Medtronic snagged FDA approval for an expanded indication for its OmniaSecure defibrillation lead. Check out why this tiny ...
TCTMD

Largest Randomized Clinical Trial Of Implantable Cardioverter Defibrillator Recipients Demonstrates Excellent Patient Outcomes With Or Without Defibrillation Testing

Boston Scientific Shockless Implant Evaluation (SIMPLE) Study Results Presented at Heart Rhythm 2014, the Heart Rhythm Society's 35th Annual Scientific Sessions The trial results demonstrated that ...